Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population

Table 4

Diagnostic performances of PCA3 and LBXexo in predicting biopsy outcomes.

Parameter	AUC	95% CI
Any-grade cancer
PSA	0.595	0.436–0.754	0.289
PCA3	0.561	0.38–0.746	0.479
LBXexo score	0.723	0.58–0.849
High-grade cancer
PSA	0.529	0.334–0.723	0.797
PCA3	0.703	0.511–0.899	0.065
LBXexo score	0.736	0.592–0.868

Abbreviations: CI, confidence interval; AUC, area under the curve. .